The US remains the most productive country in terms of biotech-related papers, with MIT and Harvard the leading universities. But numbers of papers from the EU surpassed the US last year (with Germany and the UK ahead of most EU countries); elsewhere, Korea, China and Japan also publish frequently. Overall, the number of biotech papers in NCBI's PubMed has more than doubled in the past decade (1,890 in 1994; 5,913 in 2004). Research in fields such as RNAi and proteomics appears particularly fertile.
Rights and permissions
About this article
Cite this article
Lawrence, S. Trends in the biotech literature. Nat Biotechnol 23, 408 (2005). https://doi.org/10.1038/nbt0405-408
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0405-408